Roche’s Genentech is backing this year’s Walk to End Lupus Now, taking up a sponsorship opportunity claimed by GSK in ...

Data are beginning to provide a clearer picture of chimeric antigen receptor T-cell therapy’s benefits and risks in lupus, ...

Curtis’s connection to lupus is deeply personal—rooted in a commitment to honoring his late daughter, Rashara. After her ...

For patients who have spent years managing unpredictable and debilitating autoimmune conditions like lupus, the findings ...

This national partnership strengthens efforts to fund lupus research, education, and support programs nationwide. The Lupus Foundation of America proudly announced that Genentech, a member of the ...

Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disorder in which the body’s immune system mistakenly attacks its own healthy tissues. This condition can affect multiple organs, including ...

Phase 3 trial data show that obinutuzumab significantly reduces disease activity in very active extrarenal lupus.

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Maureen McMahon, ...

Scientists may have pinpointed a primary cause of lupus, a chronic autoimmune disease. Researchers from Northwestern Medicine in Chicago and Brigham and Women’s Hospital in Boston claim they have ...

Almost 90% of a cohort of patients with systemic lupus erythematosus reported experiencing depression or depressive symptoms ...

Clinicians must balance maintaining lupus nephritis remission against the cumulative harms of long-term immunosuppressive therapy.

The walk will take place Saturday, March 21 at Tyrrell Park, bringing together survivors, families and supporters to ...